Nanomedicine Market Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2013 - 2025

Published: Apr, 2017 | Pages: 165 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global nanomedicine market is anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc. Development of novel nanotechnology-based drugs and therapies is driven by the need to develop therapies that have fewer side effects and that are more cost-effective than traditional therapies, in particular for cancer.

Application of nanotechnology-based contrast reagents for diagnosis and monitoring of the effects of drugs on an unprecedented short timescale is also attributive drive growth in the coming years. Additionally, demand for biodegradable implants with longer lifetimes that enable tissue restoration is anticipated to influence demand.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Solutions such as nanoformulations with triggered release for tailor-made pharmacokinetics, nanoparticles for local control of tumor in combination with radiotherapy, and functionalized nanoparticles for targeted in-vivo activation of stem cell production are anticipated to drive R&D, consequently resulting in revenue generation in the coming years.

Biopharmaceutical and medical devices companies are actively engaged in development of novel products as demonstrated by the increasingly growing partnerships between leading enterprises and nanomedicine startups. For instance, in November 2015, Ablynx and Novo Nordisk signed a global collaboration and a licensing agreement for development and discovery of innovative drugs with multi-specific nanobodies. This strategic partnership is anticipated to rise the net annual sales of the products uplifting the market growth.

However, in contrary with the applications of nanotechnology, the entire process of lab to market approval is a tedious and expensive one with stringent regulatory evaluation involved thereby leading investors to remain hesitant for investments.

Further key findings from the report suggest:

Therapeutics accounted for the largest share of market revenue in 2016 owing to presence of nanoemulsions, nanoformulations, or nanodevices

These devices possess the ability to cross biological barriers. Moreover, presence of drugs such as Doxil, Abraxane, and Emend is attributive for higher revenue generation

Presence of substantial number of products manufactured through the use of microbial sources can be attributed for the largest share

In-vitro diagnostics is expected to witness lucrative progress as a result of R&D carried out in this segment

Introduction of nano-enabled biomarkers, vectors and contrast agents with high-specificity and sensitivity are attributive for projected progress

Clinical cardiology is expected to witness the fastest growth through to 2025 owing to development in nano-functionalization and modification of surfaces for increased biocompatibility of implants in treatment of late thrombosis

Moreover, an abundance of research publications and patent filings from European region with a share of about 25% in nanomedicine-related publications is supportive for revenue generation from European economies

Asia Pacific is estimated to witness the fastest growth over the forecast period

Factors responsible include government and regulatory authorities that have implemented a framework to encourage R&D collaborations and framework extension.

Key players operating in this industry include Pfizer Inc., Ablynx NV, Nanotherapeutics Inc., Nanoviricides Inc., Abraxis Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, and Merck

Active expansion strategies are undertaken by a number of the major market entities in order to strengthen their position

North America dominated the industry in 2016, accounting for a 42% of total revenue

Presence of key participants operating in the region are involved in collaborative activities are attributive for the largest share of North America in sector revenue

 Table of Contents

Chapter 1 Research Methodology
                1.1 Information procurement
                1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Nanomedicine Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                    3.1.1 Market driver analysis
                        3.1.1.1 Rising level of government participation in R&D funding
                        3.1.1.2 Introduction of technological advancements in diagnostic procedures
                        3.1.1.3 Rising usage of nanomedicine in drug delivery technology
                    3.1.2 Market restraint analysis
                        3.1.2.1 Side effects associated with intake of nanoparticles and lower adoption rate by patients
                        3.1.2.2 Hesitant uptake by medical and pharmaceutical industry
                3.2 Penetration & Growth Prospect Mapping For Products, 2016 & 2025
                3.3 Nanomedicine - SWOT Analysis, By Factor (political & legal, economic and technological)
                3.4 Industry Analysis - Porter's
Chapter 4 Nanomedicine Market: Product Estimates & Trend Analysis
                4.1 Nanomedicine market: product movement analysis
                4.2 Therapeutics
                    4.2.1 Global therapeutics market, 2013 - 2025 (USD Billion)
                4.3 Regenerative medicine
                    4.3.1 Global regenerative medicine market, 2013 - 2025 (USD Billion)
                4.4 In-vitro diagnostics
                    4.4.1 Global in-vitro diagnostics market, 2013 - 2025 (USD Billion)
                4.5 In-vivo diagnostics
                    4.5.1 Global in-vivo diagnostics market, 2013 - 2025 (USD Billion)
                4.6 Vaccines
                    4.6.1 Global vaccines market, 2013 - 2025 (USD Billion)
Chapter 5 Nanomedicine Market: Application Estimates & Trend Analysis
                5.1 Nanomedicine market: Application movement analysis
                5.2 Clinical oncology
                    5.2.1 Global clinical oncology market, 2013 - 2025 (USD Billion)
                5.3 Infectious diseases
                    5.3.1 Global infectious diseases market, 2013 - 2025 (USD Billion)
                5.4 Clinical cardiology
                    5.4.1 Global clinical cardiology market, 2013 - 2025 (USD Billion)
                5.5 Orthopedics
                    5.5.1 Global orthopedics market, 2013 - 2025 (USD Billion)
                5.6 Others
                    5.6.1 Global other applications market, 2013 - 2025 (USD Billion)
Chapter 6 Nanomedicine Market: Nanomolecule Type Estimates & Trend Analysis
                6.1 Nanomedicine Market: Nanomolecule Type Movement Analysis
                6.2 Nanomolecules
                    6.2.1 Global nanomolecules market, 2013 - 2025 (USD Billion)
                    6.2.2 Nanoparticles & quantum dots
                        6.2.2.1 Global nanoparticles & quantum dots market, 2013 - 2025 (USD Billion)
                        6.2.2.2 Metal & metal compounds 
                            6.2.2.2.1 Global metal & metal compounds nanoparticles market, by type nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.2 Gold nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.3 Silver nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.4 Alumina nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.5 Iron oxide nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.6 Gadolinium nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                            6.2.2.2.7 Other metal & metal oxide nanoparticles market estimate & forecast, 2014 - 2025 (USD Billion)
                        6.2.2.3 Global metal & metal compound nanoparticles market, by application
                            6.2.2.3.1 In-vivo Imaging
                            6.2.2.3.2 Targeted drug delivery
                            6.2.2.3.3 Proton therapy
                            6.2.2.3.4 In-vitro assays
                            6.2.2.3.5 Cell & phantom imaging
                        6.2.2.4 Liposomes
                            6.2.2.4.1 Global liposomes market, 2013 - 2025 (USD Billion)
                        6.2.2.5 Polymer & polymer drug conjugates
                            6.2.2.5.1 Global polymer & polymer drug conjugates market, 2013 - 2025 (USD Billion)
                        6.2.2.6 Hydrogel nanoparticles
                            6.2.2.6.1 Global hydrogel nanoparticles market, 2013 - 2025 (USD Billion)
                        6.2.2.7 Dendrimers
                            6.2.2.7.1 Global dendrimers market, 2013 - 2025 (USD Billion)
                        6.2.2.8 Inorganic nanoparticles
                            6.2.2.8.1 Global inorganic nanoparticles market, 2013 - 2025 (USD Billion)
                    6.2.3 Nanoshells
                        6.2.3.1 Global nanoshells market, 2013 - 2025 (USD Billion)
                    6.2.4 Nanotubes
                        6.2.4.1 Global nanotubes market, 2013 - 2025 (USD Billion)
                    6.2.5 Nanodevices
                        6.2.5.1 Global nanodevices market, 2013 - 2025 (USD Billion)
Chapter 7 Nanomedicine Market: Regional Estimates & Trend Analysis, by Product, Application, & Nanomolecule Type
                7.1 Nanomedicine market share by region, 2016 & 2025
                7.2 North America
                    7.2.1 North America nanomedicine market, 2013 - 2025 (USD Billion)
                    7.2.2 U.S.
                        7.2.2.1 U.S. nanomedicine market, 2013 - 2025 (USD Billion)
                    7.2.3 Canada
                        7.2.3.1 Canada nanomedicine market, 2013 - 2025 (USD Billion)
                7.3 Europe
                    7.3.1 Europe nanomedicine market, 2013 - 2025 (USD Billion)
                    7.3.2 Germany
                        7.3.2.1 Germany nanomedicine market, 2013 - 2025 (USD Billion)
                    7.3.3 UK
                        7.3.3.1 UK nanomedicine market, 2013 - 2025 (USD Billion)
                7.4 Asia Pacific.
                    7.4.1 Asia Pacific nanomedicine market, 2013 - 2025 (USD Billion)
                    7.4.2 Japan
                        7.4.2.1 Japan nanomedicine market, 2013 - 2025 (USD Billion)
                    7.4.3 China
                        7.4.3.1 China nanomedicine market, 2013 - 2025 (USD Billion)
                7.5 Latin America
                    7.5.1 Latin America nanomedicine market, 2013 - 2025 (USD Billion)
                    7.5.2 Brazil
                        7.5.2.1 Brazil nanomedicine market, 2013 - 2025 (USD Billion)
                7.6 Middle East & Africa
                    7.6.1 Middle East & Africa nanomedicine market, 2013 - 2025 (USD Billion)
                    7.6.2 South Africa
                        7.6.2.1 South Africa nanomedicine market, 2013 - 2025 (USD Billion)
Chapter 8 Competitive Landscape
                8.1 Strategy framework
                8.2 Market participation categorization
                8.3 Company Profiles
                    8.3.1 Arrowhead Pharmaceuticals, Inc.
                        8.3.1.1 Company overview
                        8.3.1.2 CALANDO PHARMACEUTICALS, Inc.
                        8.3.1.3 Financial performance
                        8.3.1.4 Product benchmarking
                    8.3.2 Brigham and Women's Hospital (BWH)
                        8.3.2.1 Company overview
                        8.3.2.2 Financial performance
                        8.3.2.3 Product benchmarking
                    8.3.3 Nanospectra Biosciences, Inc.
                        8.3.3.1 Company overview
                        8.3.3.2 Financial performance
                        8.3.3.3 Product benchmarking
                    8.3.4 ABLYNX
                        8.3.4.1 Company overview
                        8.3.4.2 Financial performance
                        8.3.4.3 Product benchmarking
                        8.3.4.4 Strategic initiatives
                    8.3.5 AMAG Pharmaceuticals
                        8.3.5.1 Company overview
                        8.3.5.2 Financial performance
                        8.3.5.3 Product benchmarking
                        8.3.5.4 Strategic initiatives
                    8.3.6 Bio-Gate AG
                        8.3.6.1 Company overview
                        8.3.6.2 Financial performance
                        8.3.6.3 Product benchmarking
                        8.3.6.4 Strategic initiatives
                    8.3.7 Celgene Corporation
                        8.3.7.1 Company overview
                        8.3.7.2 Abraxis BioScience, Inc.
                        8.3.7.3 Financial Performance
                        8.3.7.4 Product benchmarking
                        8.3.7.5 Strategic initiatives
                    8.3.8 Johnson & Johnson Services, Inc.
                        8.3.8.1 Company overview
                        8.3.8.2 Financial performance
                        8.3.8.3 Product benchmarking
                        8.3.8.4 Strategic initiatives
                    8.3.9 Pfizer, Inc.
                        8.3.9.1 Company overview
                        8.3.9.2 Financial performance
                        8.3.9.3 Product benchmarking
                        8.3.9.4 Strategic initiatives
                    8.3.10 Abbott
                        8.3.10.1 Company overview
                        8.3.10.2 Financial performance
                        8.3.10.3 Product benchmarking
                        8.3.10.4 Strategic initiatives
                    8.3.11 Leadiant Biosciences, Inc.
                        8.3.11.1 Company overview
                        8.3.11.2 Financial performance
                        8.3.11.3 Product benchmarking
                        8.3.11.4 Strategic initiatives
                    8.3.12 Teva Pharmaceutical Industries Ltd.
                        8.3.12.1 Company overview
                        8.3.12.2 Financial performance
                        8.3.12.3 Product benchmarking
                    8.3.13 CYTIMMUNE SCIENCES, INC.
                        8.3.13.1 Company overview
                        8.3.13.2 Financial performance
                        8.3.13.3 Product benchmarking
                        8.3.13.4 Strategic initiatives
                    8.3.14 Merck & Co Ltd
                        8.3.14.1 Company Overview
                        8.3.14.2 Financial performance
                        8.3.14.3 Product benchmarking
                        8.3.14.4 Strategic initiatives
                    8.3.15 Gilead
                        8.3.15.1 Company Overview
                        8.3.15.2 Financial performance
                        8.3.15.3 Product benchmarking
                    8.3.16 Epeius Biotechnologies Corporation
                        8.3.16.1 Company overview
                        8.3.16.2 Financial performance
                        8.3.16.3 Product benchmarking

List of Tables

TABLE 1 Nanofibers in Regenerative Medicine
TABLE 2 North America nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 3 North America nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 4 North America nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 5 North America nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 6 North America nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 7 North America nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 8 North America nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 9 North America nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 10 North America metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 11 North America metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 12 North America metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 13 North America metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 14 Patent applicant for nanotechnology based therapeutics
TABLE 15 U.S. nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 16 U.S. nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 17 U.S. nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 18 U.S. nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 19 U.S. nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 20 U.S. nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 21 U.S. nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 22 U.S. nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 23 U.S. metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 24 U.S. metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 25 U.S. metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 26 U.S. metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 27 Nanotechnology organizations which are involved in publishing nanoscience based articles
TABLE 28 Canada nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 29 Canada nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 30 Canada nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 31 Canada nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 32 Canada nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 33 Canada nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 34 Canada nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 35 Canada nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 36 Canada metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 37 Canada metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 38 Canada metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 39 Canada metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 40 Europe nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 41 Europe nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 42 Europe nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 43 Europe nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 44 Europe nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 45 Europe nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 46 Europe nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 47 Europe nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 48 Europe metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 49 Europe metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 50 Europe metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 51 Europe metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 52 Germany nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 53 Germany nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 54 Germany nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 55 Germany nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 56 Germany nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 57 Germany nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 58 Germany nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 59 Germany nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 60 Germany metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 61 Germany metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 62 Germany metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 63 Germany metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 64 UK nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 65 UK nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 66 UK nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 67 UK nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 68 UK nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 69 UK nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 70 UK nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 71 UK nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 72 UK metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 73 UK metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 74 UK metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 75 UK metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 76 Asia Pacific nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 77 Asia Pacific nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 78 Asia Pacific nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 79 Asia Pacific nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 80 Asia Pacific nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 81 Asia Pacific nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 82 Asia Pacific nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 83 Asia Pacific nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 84 Asia Pacific metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 85 Asia Pacific metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 86 Asia Pacific metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 87 Asia Pacific metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 88 Japan nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 89 Japan nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 90 Japan nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 91 Japan nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 92 Japan nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 93 Japan nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 94 Japan nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 95 Japan nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 96 Japan metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 97 Japan metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 98 Japan metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 99 Japan metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 100 China nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 101 China nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 102 China nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 103 China nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 104 China nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 105 China nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 106 China nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 107 China nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 108 China metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 109 China metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 110 China metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 111 China metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 112 Latin America nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 113 Latin America nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 114 Latin America nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 115 Latin America nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 116 Latin America nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 117 Latin America nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 118 Latin America nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 119 Latin America nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 120 Latin America metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 121 Latin America metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 122 Latin America metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 123 Latin America metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 124 Brazil nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 125 Brazil nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 126 Brazil nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 127 Brazil nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 128 Brazil nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 129 Brazil nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 130 Brazil nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 131 Brazil nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 132 Brazil metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 133 Brazil metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 134 Brazil metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 135 Brazil metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 136 MEA nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 137 MEA nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 138 MEA nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 139 MEA nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 140 MEA nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 141 MEA nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 142 MEA nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 143 MEA nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 144 MEA metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 145 MEA metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 146 MEA metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 147 MEA metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 148 South Africa nanomedicine market estimates, by product, 2013 - 2016 (USD Billion))
TABLE 149 South Africa nanomedicine market forecasts, by product, 2017 - 2025 (USD Billion)
TABLE 150 South Africa nanomedicine market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 151 South Africa nanomedicine market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 152 South Africa nanomedicine market estimates, by nanomolecule type, 2013 - 2016 (USD Billion)
TABLE 153 South Africa nanomedicine market forecasts, by nanomolecule type, 2017 - 2025 (USD Billion)
TABLE 154 South Africa nanoparticle market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 155 South Africa nanoparticle market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 156 South Africa metal and metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 157 South Africa metal and metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 158 South Africa metal & metal oxides nanoparticles market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 159 South Africa metal & metal oxides nanoparticles market forecasts, by application, 2017 - 2025 (USD Billion)

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.